2026 Global: Nuclear Medicine Equipment Market -Competitive Review (2032) report
Description
The 2026 Global: Nuclear Medicine Equipment Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems are among the most influential firms in the nuclear medicine equipment market. These companies design and manufacture imaging modalities such as PET/CT and SPECT scanners, gamma cameras, and related software, as well as cyclotrons and radiopharmacy infrastructure that support radiotracer production. GE Healthcare, headquartered in Chicago, United States, offers a broad PET/CT portfolio, SPECT systems, and integrated service networks. Siemens Healthineers, based in Erlangen, Germany, provides high‑end PET/CT platforms and gamma cameras, complemented by AI‑enabled analytics and global service coverage. Philips Healthcare, headquartered in Amsterdam, Netherlands, delivers comprehensive imaging solutions that emphasize dose management and workflow efficiency. Canon Medical Systems, Otawara, Tochigi, Japan, markets PET/CT and SPECT/CT platforms widely used in oncology and neurology, with a robust installer network. Hitachi Medical Systems, Tokyo, Japan, focuses on PET/CT and SPECT imaging with compact system designs for diverse clinical settings.
Shimadzu Corporation, based in Kyoto, Japan, is a longstanding supplier of gamma cameras and SPECT systems, complemented by PET/CT capabilities and precision detectors used in research and clinical practice. Mediso, headquartered in Budapest, Hungary, offers integrated nuclear medicine solutions, including dual‑modality SPECT/CT and PET/CT systems, small‑animal imaging, and lightweight modular software that enables cross‑facility data sharing. Ion Beam Applications (IBA), headquartered in Louvain‑la‑Neuve, Belgium, is a leading cyclotron and radiopharmacy equipment provider, delivering compact accelerators, automated radiochemistry suites, and PET radiopharmaceutical production lines that support clinical supply chains and research programs. Together, these firms broaden regional access to nuclear medicine technology by providing flexible configurations, service networks, and training programs for clinicians, technologists, and researchers. Their portfolios contribute to regional disease management strategies, enabling early detection, personalized therapy planning, and multicenter clinical trials that advance nuclear medicine's evidence base. Collaboration with academic centers strengthens technology transfer and regulatory familiarity worldwide.
Eckert & Ziegler Strahlen- und Medizintechnik, headquartered in Berlin, Germany, specializes in radiopharmaceutical production equipment, compact dosing systems, and ancillary hardware that support safe, compliant distribution of radiotracers for diagnostic and therapeutic applications. The company also serves as a supplier for quality control instrumentation and regulatory compliance solutions used in clinical radiopharmacy. Varex Imaging, based in Salt Lake City, Utah, United States, provides gamma cameras, detectors, and imaging components that underpin many nuclear medicine and interventional radiology workflows. Its high‑resolution detectors and advanced software offerings enable improved lesion detectability, quantification, and workflow efficiency across research and hospital settings. Together, Eckert & Ziegler and Varex Imaging complete the equipment ecosystem by supplying critical radiopharmacy infrastructure and detector technology that connect radiotracer production with final‑stage diagnostic imaging, supporting clinicians, technologists, and researchers in delivering precise, timely patient care. Their collaboration fosters innovation in quality control, safety standards, and dose optimization worldwide today.
GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems are among the most influential firms in the nuclear medicine equipment market. These companies design and manufacture imaging modalities such as PET/CT and SPECT scanners, gamma cameras, and related software, as well as cyclotrons and radiopharmacy infrastructure that support radiotracer production. GE Healthcare, headquartered in Chicago, United States, offers a broad PET/CT portfolio, SPECT systems, and integrated service networks. Siemens Healthineers, based in Erlangen, Germany, provides high‑end PET/CT platforms and gamma cameras, complemented by AI‑enabled analytics and global service coverage. Philips Healthcare, headquartered in Amsterdam, Netherlands, delivers comprehensive imaging solutions that emphasize dose management and workflow efficiency. Canon Medical Systems, Otawara, Tochigi, Japan, markets PET/CT and SPECT/CT platforms widely used in oncology and neurology, with a robust installer network. Hitachi Medical Systems, Tokyo, Japan, focuses on PET/CT and SPECT imaging with compact system designs for diverse clinical settings.
Shimadzu Corporation, based in Kyoto, Japan, is a longstanding supplier of gamma cameras and SPECT systems, complemented by PET/CT capabilities and precision detectors used in research and clinical practice. Mediso, headquartered in Budapest, Hungary, offers integrated nuclear medicine solutions, including dual‑modality SPECT/CT and PET/CT systems, small‑animal imaging, and lightweight modular software that enables cross‑facility data sharing. Ion Beam Applications (IBA), headquartered in Louvain‑la‑Neuve, Belgium, is a leading cyclotron and radiopharmacy equipment provider, delivering compact accelerators, automated radiochemistry suites, and PET radiopharmaceutical production lines that support clinical supply chains and research programs. Together, these firms broaden regional access to nuclear medicine technology by providing flexible configurations, service networks, and training programs for clinicians, technologists, and researchers. Their portfolios contribute to regional disease management strategies, enabling early detection, personalized therapy planning, and multicenter clinical trials that advance nuclear medicine's evidence base. Collaboration with academic centers strengthens technology transfer and regulatory familiarity worldwide.
Eckert & Ziegler Strahlen- und Medizintechnik, headquartered in Berlin, Germany, specializes in radiopharmaceutical production equipment, compact dosing systems, and ancillary hardware that support safe, compliant distribution of radiotracers for diagnostic and therapeutic applications. The company also serves as a supplier for quality control instrumentation and regulatory compliance solutions used in clinical radiopharmacy. Varex Imaging, based in Salt Lake City, Utah, United States, provides gamma cameras, detectors, and imaging components that underpin many nuclear medicine and interventional radiology workflows. Its high‑resolution detectors and advanced software offerings enable improved lesion detectability, quantification, and workflow efficiency across research and hospital settings. Together, Eckert & Ziegler and Varex Imaging complete the equipment ecosystem by supplying critical radiopharmacy infrastructure and detector technology that connect radiotracer production with final‑stage diagnostic imaging, supporting clinicians, technologists, and researchers in delivering precise, timely patient care. Their collaboration fosters innovation in quality control, safety standards, and dose optimization worldwide today.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
